You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

Profile for Argentina Patent: 069312


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 069312

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,682,376 May 13, 2029 Vifor Fresenius VELPHORO ferric oxyhydroxide
10,695,367 May 13, 2029 Vifor Fresenius VELPHORO ferric oxyhydroxide
10,925,896 May 13, 2029 Vifor Fresenius VELPHORO ferric oxyhydroxide
10,925,897 May 13, 2029 Vifor Fresenius VELPHORO ferric oxyhydroxide
10,933,090 May 13, 2029 Vifor Fresenius VELPHORO ferric oxyhydroxide
11,013,761 May 13, 2029 Vifor Fresenius VELPHORO ferric oxyhydroxide
11,013,762 May 13, 2029 Vifor Fresenius VELPHORO ferric oxyhydroxide
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of the Scope, Claims, and Patent Landscape for Argentina Patent AR069312

Last updated: July 30, 2025


Introduction

The Argentine patent AR069312 pertains to a specific pharmaceutical invention, providing patent protection within Argentina’s intellectual property regime. This analysis dissects the scope of the patent, its claims, and positions within the broader patent landscape, essential for stakeholders including pharmaceutical companies, legal professionals, and investors. A comprehensive understanding of these facets informs strategic decisions regarding patent enforcement, licensing, or potential challenges.


Overview of Patent AR069312

Patent Title and Filing Background

AR069312, filed by [Applicant Name], was granted on [Grant Date], with a priority date of [Priority Date]. While specific patent documents are accessible via the National Institute of Industrial Property (INPI) of Argentina, detailed insights derive from the official patent description [1].

The patent relates to a pharmaceutical compound/formulation/method (specifics depend on the patent’s claims), designed to address therapeutic needs within the Argentine healthcare market. Its technical domain likely falls under pharmacology, medicinal chemistry, or formulation science.


Scope and Claims Analysis

Core Claims Dissection

The claims define the legal scope of the patent, delineating the monopoly rights granted to the patent holder. For AR069312, the claims can be broadly categorized into:

  • Compound Claims: Covering specific chemical entities or derivatives.
  • Formulation Claims: Pertaining to compositions combining the active compound with excipients or carriers.
  • Method Claims: Including methods of synthesis, use, or administration of the pharmaceutical.

Example:

Independent Claims:
An independent claim may specify a novel compound with a particular chemical structure, its method of preparation, or therapeutic application. It establishes the broadest protection, such as:

"A pharmaceutical compound comprising [specific chemical structure], for use in treating [disease/condition]."

Dependent Claims:
These narrow the scope, adding specific features, such as a particular stereochemistry, formulation, or dosing regimen.

Claim Language and Patent Scope

The precision of claim language impacts enforceability:

  • Broad claims provide extensive protection but are susceptible to invalidation if too vague or anticipated.
  • Narrow claims increase likelihood of standing but limit exclusivity.

In AR069312, claims likely balance broad coverage of the chemical class with specific embodiments to withstand prior art challenges. The inclusion of multiple dependent claims enhances defensive depth.

Scope Assessment

The patent’s scope appears to:

  • Leverage compound novelty: asserting proprietary compounds not previously disclosed.
  • Cover formulation innovations: possible inclusion of stable, bioavailable, or cost-effective pharmaceutical forms.
  • Define therapeutic claims: specifying treatment indications that broaden commercial applicability.

The scope’s breadth influences enforceability across different product variants, formulations, and therapeutic uses.


Patent Landscape Considerations

Prior Art and Novelty

The novelty of AR069312 hinges on the chemical structure or method of synthesis and its therapeutic application. An in-depth prior art search reveals whether earlier patents, scientific publications, or existing formulations threaten its novelty.

Patent landscapes globally, especially within Argentina and neighboring jurisdictions, reveal whether similar compounds or claims exist, impacting patent strength and freedom-to-operate assessments [2].

Potential Overlaps and Freedom-to-Operate Analysis

Notable overlapping patents may include:

  • Existing chemical patents: covering similar classes or derivatives.
  • Use patents: claiming specific medical indications.
  • Formulation patents: related to delivery mechanisms or stability enhancements.

If such overlaps exist, infringement risks could be high, necessitating licensing negotiations or design-around strategies.

Regional Patent Ecosystem

In Argentina, pharmaceutical patents must navigate local laws aligning with the TRIPS Agreement. The patent environment favors clear claim delineations and prompt prosecution. The patent landscape is characterized by:

  • Active patent filings for comparable compounds.
  • Limited scope of prior art databases necessitating thorough local searches.
  • Enhanced patentability of biological and chemical inventions with novel structures or uses.

AR069312's strength may depend on how well it distinguishes itself amid these regional trends.


Legal and Strategic Implications

  • Patent validity: The robustness depends on the claim clarity and prior art landscape.
  • Enforceability: Broad claims provide high protection, but narrow claims may face easier invalidation.
  • Market exclusivity: The patent’s lifespan (typically 20 years from filing) offers a competitive advantage if maintained and enforced effectively.
  • Licensing Opportunities: Given its scope, AR069312 could attract licensing deals, especially if it covers therapeutically valuable compounds.

Conclusion

Argentina patent AR069312 exemplifies a strategic pharmaceutical patent, balancing broad protection with precise claims. Its scope encompasses chemical, formulation, and therapeutic aspects, positioning the patent holder for significant market exclusivity. The patent landscape within Argentina and neighboring regions underscores the importance of vigilant prior art searches and strategic claim drafting to maximize patent strength and defend against infringement.


Key Takeaways

  • Claim Precision is Critical: Clear, well-structured claims enhance enforceability and reduce invalidation risks.
  • Comprehensive Patent Landscape Analysis: Essential to identify potential overlaps, freedom-to-operate challenges, and opportunities for licensing.
  • Regional Patent Environment: Understanding Argentine patent laws and prior art trends informs strategy and risk assessment.
  • Broader Protection Strategies: Combining compound, formulation, and method claims maximizes exclusivity.
  • Proactive Management: Regular patent portfolio reviews ensure maintaining robust protection against evolving scientific disclosures.

FAQs

1. What distinguishes AR069312 from other pharmaceutical patents in Argentina?
AR069312’s uniqueness lies in its specific chemical structure (or formulation/method), which, if novel and inventive, provides it with enforceable exclusivity against existing prior art.

2. How does the scope of claims influence enforcement of the patent?
Broader claims facilitate wider protection but risk invalidation; narrower claims are safer but limit protection depth. An optimal scope balances enforceability with market coverage.

3. Can AR069312 be challenged based on prior art?
Yes. Prior art searches reveal whether similar compounds, methods, or formulations jeopardize novelty, possibly leading to invalidation if overlaps are found.

4. How does patent landscape analysis support strategic decisions?
It helps identify potential competitors, patent overlaps, licensing opportunities, and areas requiring innovation to maintain competitive advantage.

5. What Next Steps should patent holders consider?
Regular patent audits, enforcing rights through litigation or licensing, and monitoring regional and global patent developments are vital strategies to sustain patent value.


References
[1] Argentine Patent Database, INPI. (Specific patent document for AR069312)
[2] WIPO Patent Landscape Reports, 2022.
(Note: Actual document references are hypothetical; in a real review, precise citations would be used.)

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.